No definition available.
Dementia due to Parkinsons disease, excluding more controls
PD_DEMENTIA_EXMORE
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- G6_PARKINSON, F5_PSYCH, NEURODIS
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Dementia due to Parkinsons disease, excluding more controls
based on the number of shared cases.
Similar with more cases:
- Dementia due to Parkinson's disease
- Dementia in other diseases classified elsewhere
- Any dementia, excluding more controls
- Any dementia
- Dementia
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 9967 | 4278 | 5570 |
| Only index persons | 8196 | 3544 | 4652 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.14 | 0.12 | 0.16 |
| Only index persons | 0.16 | 0.13 | 0.18 |
| Median age at first event (years) | |||
| Whole population | 77.63 | 78.85 | 76.70 |
| Only index persons | 77.59 | 78.87 | 76.63 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 778 | 271 | 507 |
| Unadjusted period prevalence (%) | 0.18 | 0.09 | 0.22 |
| Median age at first event (years) | 76.78 | 77.88 | 76.19 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 664
- Matched controls
- 6639
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G20
ICD-10 Finland
Parkinson disease
4503599627370496.0
323.0
630
*
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
6732.6
323.0
626
16
N06DA03
ATC
rivastigmine; oral, transdermal
1833.7
323.0
351
*
N04BD01
ATC
selegiline; oral
5021.9
323.0
304
*
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
+∞
323.0
600
*
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
+∞
323.0
286
*
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
+∞
323.0
536
*
N87
ICPC
Parkinsonism
+∞
309.2
272
*
N05AH04
ATC
quetiapine; oral
48.8
252.2
309
116
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
+∞
229.9
207
*
N04BC05
ATC
pramipexole; oral
38.9
229.6
298
136
N04BD02
ATC
rasagiline; oral
+∞
179.5
164
*
N04BC04
ATC
ropinirole; oral
689.5
168.0
159
*
193
Kela drug reimbursment
Rasagiline
+∞
145.2
134
*
F02.39
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
+∞
131.7
122
*
AA1AD
NOMESCO Finland
CT of head and brain
11.1
130.5
284
418
N04BX02
ATC
entacapone; oral
+∞
127.2
118
*
R53
ICD-10 Finland
Malaise and fatigue
7.4
92.5
259
525
N03AE01
ATC
clonazepam; systemic
25.5
89.1
127
61
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
5.5
84.4
333
1023
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
316.0
83.6
83
*
N06DX01
ATC
memantine; oral
90.9
79.3
87
11
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
6.4
78.0
242
544
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
146.9
74.7
78
6
N06DA02
ATC
donepezil; oral
66.6
71.6
82
14
S06.0
ICD-10 Finland
Concussion
34.5
69.0
90
30
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
356.6
64.6
64
*
I95.1
ICD-10 Finland
Orthostatic hypotension
15.5
62.7
106
80
N05AX08
ATC
risperidone; systemic
23.2
62.6
91
45
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
77.9
62.5
70
10
H02AA02
ATC
fludrocortisone; oral
78.3
57.2
64
9
N04AA02
ATC
biperiden; systemic
583.9
55.4
54
*
N06AX11
ATC
mirtazapine; oral
4.5
54.8
236
720
A06AD11
ATC
lactulose; oral
4.8
54.7
220
626
R25.1
ICD-10 Finland
Tremor, unspecified
29.7
53.4
72
27
N04BC09
ATC
rotigotine; transdermal
+∞
52.8
50
*
N05BA04
ATC
oxazepam; oral
4.8
52.5
205
563
N06AB10
ATC
escitalopram; oral
8.2
52.3
125
183
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.8
51.6
304
1216
A28
ICPC
Limited function/disability NOS
4.5
49.0
207
609
SPAT1216
SPAT
Assessment of functional ability
4.8
48.7
188
505
F02.30
ICD-10 Finland
Dementia in Parkinson's disease without additional symptoms
+∞
47.5
45
*
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
10.1
47.2
98
112
N06AB04
ATC
citalopram; systemic
5.1
45.0
159
385
N04BB01
ATC
amantadine; oral
26.2
44.5
62
26
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
+∞
44.2
42
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
20.8
44.1
66
35
SPAT1229
SPAT
Assessment of need for aid
6.4
41.0
115
209
F32.9
ICD-10 Finland
Depressive episode, unspecified
25.8
40.9
57
24
SPAT1234
SPAT
Support of social functional capacity
9.5
40.7
87
104
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
4.1
40.7
185
570
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
7.2
40.5
104
167
XA800
NOMESCO Finland
Neuropsychological investigation
80.4
40.4
45
6
SPAT1215
SPAT
Assessment of need for medical rehabilitation
13.1
40.1
72
61
S01.0
ICD-10 Finland
Open wound of scalp
7.2
39.8
102
163
G04BD12
ATC
mirabegron; oral
4.9
39.6
143
350
N04BC06
ATC
cabergoline; oral (dopamine agonists)
410.3
39.5
39
*
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
8.1
38.0
89
124
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
3.3
37.9
247
1012
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.7
37.8
144
371
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
23.4
37.6
54
25
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
4.3
36.7
155
441
F03
ICD-10 Finland
Unspecified dementia
27.7
35.9
49
19
P20
ICPC
Memory disturbance
4.6
35.6
136
350
SPAT1222
SPAT
Counselling/guidance promoting independent living
3.9
35.4
171
548
G02CB01
ATC
bromocriptine; systemic
365.4
35.3
35
*
N29
ICPC
Neurological sympt/complt other
34.3
34.9
45
14
SPAT1231
SPAT
Assessment of adjustments needed in living environment
17.0
34.4
55
35
N19
ICPC
Speech disorder
354.2
34.2
34
*
L28
ICPC
Limited function/disability (L)
3.7
33.9
170
560
F02.32
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly hallucinations
+∞
33.6
32
*
N05AH03
ATC
olanzapine; systemic
67.0
33.4
38
6
W19
ICD-10 Finland
Unspecified fall
5.6
32.7
102
209
N04BC02
ATC
pergolide; oral
+∞
32.6
31
*
S72.0
ICD-10 Finland
Fracture of neck of femur
6.7
32.4
87
147
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.8
31.7
151
474
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
+∞
31.5
30
*
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
+∞
30.4
29
*
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
18.9
30.1
46
26
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
47.4
29.9
36
8
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
6.4
29.6
81
140
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
+∞
29.4
28
*
G47.3
ICD-10 Finland
Sleep apnoea
13.7
29.4
51
40
Z2445
NOMESCO Finland
Psychologist
57.7
28.4
33
6
R41.0
ICD-10 Finland
Disorientation, unspecified
14.0
27.3
47
36
F0230, G20
ICD-10 Finland
NA
+∞
27.3
26
*
F0232, G20
ICD-10 Finland
NA
+∞
27.3
26
*
D21
ICPC
Swallowing problem
22.9
27.2
39
18
F05.9
ICD-10 Finland
Delirium, unspecified
64.8
27.2
31
5
N06AX16
ATC
venlafaxine; oral
8.4
26.3
59
76
Z75.5
ICD-10 Finland
Holiday relief care
62.7
26.2
30
5
A04
ICPC
Weakness/tiredness general
4.0
26.1
114
327
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
9.8
26.0
53
58
SPAT1254
SPAT
Administration of medicine
3.5
25.9
137
462
G40.9
ICD-10 Finland
Epilepsy, unspecified
270.4
25.9
26
*
SPAT1053
SPAT
Memory test
3.1
25.8
169
665
SPAT1245
SPAT
Provision of support and information to patient’s family members
6.8
25.8
67
108
G30.1
ICD-10 Finland
Alzheimer disease with late onset
23.7
25.5
36
16
WYA20
NOMESCO Finland
Home visit
31.5
25.2
33
11
AAG20
NOMESCO Finland
Stereotactic intracranial implantation of electrodes
+∞
25.2
24
*
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
6.7
24.9
65
105
R4130
NOMESCO Finland
Speech therapy
23.0
24.6
35
16
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
+∞
24.1
23
*
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
4.2
23.7
95
251
R55
ICD-10 Finland
Syncope and collapse
3.5
23.2
117
378
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
+∞
23.0
22
*
SPAT1172
SPAT
Guidance concerning hydration
9.0
23.0
49
58
XF606
NOMESCO Finland
Ortostatic test
31.3
23.0
30
10
N99
ICPC
Neurological disease other
86.5
22.8
25
*
C07AA05
ATC
propranolol; systemic
3.5
22.5
114
369
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
+∞
22.0
21
*
N03AG01
ATC
valproic acid; systemic, rectal
64.8
22.0
25
*
R41.3
ICD-10 Finland
Other amnesia
19.2
21.9
33
18
N06AX21
ATC
duloxetine; oral
6.5
21.6
57
94
N28
ICPC
Limited function/disability (N)
44.9
21.5
26
6
R1250
NOMESCO Finland
Evaluation of functional capability
15.3
21.4
35
24
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
6.9
21.3
54
84
N02BE01
ATC
paracetamol; systemic, rectal
2.5
21.2
537
4170
SPAT1167
SPAT
Insertion of urinary catheter
6.1
20.9
58
102
S70.0
ICD-10 Finland
Contusion of hip
7.5
20.5
49
70
N39.4
ICD-10 Finland
Other specified urinary incontinence
4.5
20.2
75
184
K90
ICPC
Stroke/cerebrovascular accident
41.4
19.6
24
6
N30.0
ICD-10 Finland
Acute cystitis
3.2
19.6
110
383
E86
ICD-10 Finland
Volume depletion
10.0
19.1
38
40
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
17.8
18.8
29
17
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
+∞
18.8
18
*
3320A
ICD-9 Finland
Parkinson's disease, Paralysis agitans
+∞
18.8
18
*
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
+∞
18.8
18
*
K91
ICPC
Cerebrovascular disease
195.1
18.6
19
*
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
195.1
18.6
19
*
N05BA06
ATC
lorazepam; systemic, sublingual
5.6
18.4
55
106
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
6.4
18.4
49
82
P70
ICPC
Dementia
25.9
18.3
25
10
SPAT1305
SPAT
Counselling and guidance related to physical exercise
3.6
18.2
86
262
R35
ICD-10 Finland
Polyuria
4.2
18.1
72
188
N05AH02
ATC
clozapine; systemic
+∞
17.8
17
*
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
+∞
17.8
17
*
U04
ICPC
Incontinence urine
5.2
17.7
56
116
G72.8
ICD-10 Finland
Other specified myopathies
184.6
17.6
18
*
L89
ICD-10 Finland
Decubitus ulcer and pressure area
12.4
17.5
31
26
F05.1
ICD-10 Finland
Delirium superimposed on dementia
+∞
16.7
16
*
N05BA01
ATC
diazepam; systemic, rectal
3.2
16.5
94
329
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
5.8
16.5
47
86
M48.0
ICD-10 Finland
Spinal stenosis
3.0
16.4
102
379
N03AF02
ATC
oxcarbazepine; oral
61.5
15.8
18
*
XKD06
NOMESCO Finland
Physiologic investigation of micturition
6.7
15.7
40
63
F02.31
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly paranoidism
+∞
15.7
15
*
F02.3
ICD-10 Finland
Dementia in Parkinson disease
+∞
15.7
15
*
F05.8
ICD-10 Finland
Other delirium
+∞
15.7
15
*
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
27.0
15.7
21
8
G30.8
ICD-10 Finland
Other Alzheimer disease
22.7
15.6
22
10
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
163.6
15.5
16
*
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.9
15.5
98
368
R47.1
ICD-10 Finland
Dysarthria and anarthria
46.1
15.1
18
*
NA1AD
NOMESCO Finland
Cervical spine CT examination
7.3
15.1
36
52
JDB10
NOMESCO Finland
Percutaneous gastrostomy
12.8
15.0
26
21
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
7.1
14.9
36
53
G23.1
ICD-10 Finland
Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]
+∞
14.6
14
*
F02.34
ICD-10 Finland
Dementia in Parkinson's disease, other additional symptoms of mixed type
+∞
14.6
14
*
N03AX12
ATC
gabapentin; oral
3.0
14.6
91
337
R13
ICD-10 Finland
Dysphagia
4.0
14.6
59
157
K59.0
ICD-10 Finland
Constipation
3.9
14.3
59
160
N06AX03
ATC
mianserin; oral
6.6
14.2
36
57
NF1AA
NOMESCO Finland
Hip X-ray examination
3.0
13.8
84
307
G04BD09
ATC
trospium; oral
5.8
13.8
39
71
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.7
13.7
100
407
R42
ICD-10 Finland
Dizziness and giddiness
2.3
13.7
140
687
F22.0
ICD-10 Finland
Delusional disorder
76.7
13.6
15
*
N03AX16
ATC
pregabalin; oral
2.4
13.6
126
586
G23.9
ICD-10 Finland
Degenerative disease of basal ganglia, unspecified
+∞
13.6
13
*
F0234, G20
ICD-10 Finland
NA
+∞
13.6
13
*
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
+∞
13.6
13
*
F023, G20
ICD-10 Finland
NA
+∞
13.6
13
*
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
6.7
13.5
34
53
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
142.7
13.5
14
*
F00.10
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
142.7
13.5
14
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
7.3
13.2
31
44
G25.0
ICD-10 Finland
Essential tremor
12.5
13.2
23
19
G56.0
ICD-10 Finland
Carpal tunnel syndrome
8.5
13.1
28
34
J01EA01
ATC
trimethoprim; systemic
2.1
12.8
169
928
K59.09
ICD-10 Finland
Constipation, unspecified
3.7
12.6
56
162
N06AX12
ATC
bupropion; oral
17.7
12.6
19
11
85000
ICD-8 Finland
Concussion, Current or unspecified
+∞
12.5
12
*
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
+∞
12.5
12
*
Z02.4
ICD-10 Finland
Examination for driving licence
0.4
12.5
74
1503
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
132.3
12.5
13
*
R60.0
ICD-10 Finland
Localized oedema
2.7
12.4
91
374
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.2
12.3
67
227
B01AC07
ATC
dipyridamole; systemic
3.7
12.3
55
160
F01.9
ICD-10 Finland
Vascular dementia, unspecified
38.3
12.2
15
*
N05CD07
ATC
temazepam; oral
2.5
12.2
103
456
A06AC01
ATC
ispaghula (psylla seeds); oral
2.1
12.2
158
860
R32
ICD-10 Finland
Unspecified urinary incontinence
6.6
12.0
30
47
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.4
11.8
111
521
G04CA02
ATC
tamsulosin; oral
1.9
11.8
240
1547
UKC02
NOMESCO Finland
Cystoscopy
2.1
11.7
156
855
R56.8
ICD-10 Finland
Other and unspecified convulsions
8.3
11.6
25
31
Y94.0
ICD-10 Finland
Accident at home
9.5
11.6
23
25
130
Kela drug reimbursment
Malignant tumour
0.2
11.5
12
558
N30.9
ICD-10 Finland
Cystitis, unspecified
3.7
11.4
50
144
T36
ICD-10 Finland
Poisoning by systemic antibiotics
15.4
11.4
18
12
J01CA08
ATC
pivmecillinam; oral
1.9
11.3
195
1180
N05CF01
ATC
zopiclone; oral
1.9
11.3
211
1314
SPAT1360
SPAT
Extensive global examination
3.0
11.3
66
235
P29
ICPC
Psychological sympt/compl other
13.0
11.2
19
15
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.3
11.1
107
507
N06AA12
ATC
doxepin; systemic
4.6
11.1
38
87
Z3226
NOMESCO Finland
Physiotherapist
2.2
11.1
123
620
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
6.6
10.9
27
42
Z50.5
ICD-10 Finland
Speech therapy
18.2
10.8
16
9
R44.1
ICD-10 Finland
Visual hallucinations
28.5
10.8
14
5
N02AA05
ATC
oxycodone; systemic
2.1
10.6
126
654
R33
ICD-10 Finland
Retention of urine
2.5
10.6
83
354
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
10.5
115
578
I95.9
ICD-10 Finland
Hypotension, unspecified
7.9
10.5
23
30
R1260
NOMESCO Finland
Evaluation of communicative skills
7.9
10.5
23
30
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
111.6
10.4
11
*
F06.0
ICD-10 Finland
Organic hallucinosis
111.6
10.4
11
*
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
111.6
10.4
11
*
AA5EN
NOMESCO Finland
Brain reseptor or transprot protein distribution isotope imaging
+∞
10.4
10
*
N86
ICPC
Multiple sclerosis
+∞
10.4
10
*
30041
ICD-8 Finland
Neuroses, Depressiva
+∞
10.4
10
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.8
10.4
262
1791
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.1
10.2
131
705
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.9
10.2
63
233
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
11.5
10.1
18
16
SPAT1262
SPAT
Handing over of treatment supplies
2.1
10.1
128
682
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
10.0
221
1445
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
17.0
9.9
15
9
F06.7
ICD-10 Finland
Mild cognitive disorder
12.4
9.9
17
14
S01.9
ICD-10 Finland
Open wound of head, part unspecified
8.9
9.8
20
23
F34.1
ICD-10 Finland
Dysthymia
55.8
9.7
11
*
C03CA01
ATC
furosemide; systemic
1.7
9.6
284
2025
X59
ICD-10 Finland
Exposure to unspecified factor
2.3
9.6
92
435
XKD00
NOMESCO Finland
Uroflowmetry
1.9
9.5
165
989
R07.4
ICD-10 Finland
Chest pain, unspecified
1.9
9.5
168
1015
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
101.4
9.4
10
*
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
101.4
9.4
10
*
G35
ICD-10 Finland
Multiple sclerosis
+∞
9.4
9
*
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
+∞
9.4
9
*
N04BX01
ATC
tolcapone; oral
+∞
9.4
9
*
F99
ICD-10 Finland
Mental disorder, not otherwise specified
+∞
9.4
9
*
F0029, G308
ICD-10 Finland
NA
+∞
9.4
9
*
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
+∞
9.4
9
*
G04BD11
ATC
fesoterodine; oral
3.8
9.4
39
108
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
9.7
9.3
18
19
J01DB01
ATC
cefalexin; oral
1.7
9.3
445
3619
S01
ICD-10 Finland
Open wound of head
7.9
9.2
20
26
S00.9
ICD-10 Finland
Superficial injury of head, part unspecified
11.7
9.1
16
14
F32.1
ICD-10 Finland
Moderate depressive episode
37.2
9.0
11
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.3
9.0
32
77
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
24.4
8.9
12
5
M54.5
ICD-10 Finland
Low back pain
1.9
8.9
149
882
R23
ICPC
Voice symptom/complaint
8.8
8.8
18
21
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.2
8.7
89
432
N18
ICPC
Paralysis/weakness
14.3
8.7
14
10
M01AH02
ATC
rofecoxib; oral
2.2
8.7
93
461
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
7.8
8.7
19
25
G04BD07
ATC
tolterodine; oral
3.0
8.6
49
171
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.9
8.6
27
57
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
8.4
8.6
18
22
N06DA04
ATC
galantamine; oral
20.3
8.5
12
6
S72.1
ICD-10 Finland
Pertrochanteric fracture
4.2
8.5
31
77
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
91.1
8.4
9
*
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
91.1
8.4
9
*
G04BD04
ATC
oxybutynin; oral, transdermal
2.9
8.4
49
175
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
8.0
8.4
18
23
N05AB03
ATC
perphenazine; systemic, rectal
13.0
8.4
14
11
SPAT1263
SPAT
Sampling
1.7
8.4
242
1694
N04BC01
ATC
bromocriptine; oral
+∞
8.3
8
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
+∞
8.3
8
*
I63.8
ICD-10 Finland
Other cerebral infarction
+∞
8.3
8
*
G21.1
ICD-10 Finland
Other drug-induced secondary parkinsonism
+∞
8.3
8
*
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
+∞
8.3
8
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
+∞
8.3
8
*
SPAT1125
SPAT
Stoma care and guidance
5.3
8.2
24
47
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
3.2
8.2
42
138
G04BD08
ATC
solifenacin; oral
2.7
8.2
53
203
SPAT1301
SPAT
No procedures
1.7
8.2
198
1319
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
33.8
8.1
10
*
N03AX09
ATC
lamotrigine; oral
33.8
8.1
10
*
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
22.3
8.0
11
5
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.3
8.0
70
317
TAB00
NOMESCO Finland
Lumbar puncture
7.9
7.9
17
22
N06AB03
ATC
fluoxetine; oral
3.0
7.9
45
158
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
1.9
7.9
128
749
ZXD05
NOMESCO Finland
Urgent procedure
1.7
7.8
192
1278
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
11.0
7.8
14
13
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
11.0
7.8
14
13
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
3.0
7.8
44
153
R11
ICD-10 Finland
Nausea and vomiting
2.8
7.6
46
169
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.8
7.6
48
180
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
4.4
7.6
26
61
R29.6
ICD-10 Finland
Tendency to fall, not elsewhere classified
25.3
7.6
10
*
S22.3
ICD-10 Finland
Fracture of rib
2.9
7.5
44
158
N06AX26
ATC
vortioxetine; oral
7.2
7.5
17
24
G30.0
ICD-10 Finland
Alzheimer disease with early onset
80.9
7.4
8
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
80.9
7.4
8
*
F29
ICD-10 Finland
Unspecified nonorganic psychosis
80.9
7.4
8
*
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
5.0
7.3
22
45
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
11.0
7.3
13
12
F06.2
ICD-10 Finland
Organic delusional [schizophrenia-like] disorder
+∞
7.3
7
*
N05AX12
ATC
aripiprazole; systemic
+∞
7.3
7
*
N04AA01
ATC
trihexyphenidyl; oral
+∞
7.3
7
*
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
+∞
7.3
7
*
S06.6
ICD-10 Finland
Traumatic subarachnoid haemorrhage
+∞
7.3
7
*
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
+∞
7.3
7
*
G21.8
ICD-10 Finland
Other secondary parkinsonism
+∞
7.3
7
*
Z60.8
ICD-10 Finland
Other problems related to social environment
+∞
7.3
7
*
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
15.9
7.2
11
7
N03AX14
ATC
levetiracetam; systemic
30.3
7.2
9
*
N05AF03
ATC
chlorprothixene; systemic
30.3
7.2
9
*
H50.31
ICD-10 Finland
Intermittent exotropia
30.3
7.2
9
*
SPAT1279
SPAT
Preparation of immediate hospitalisation
8.0
7.1
15
19
A02BC05
ATC
esomeprazole; systemic
1.6
7.1
209
1457
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.5
7.0
55
234
N03AF01
ATC
carbamazepine; oral, rectal
5.3
7.0
20
39
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
3.5
6.9
30
88
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.0
6.9
37
127
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
16.9
6.8
10
6
N06AB06
ATC
sertraline; oral
3.5
6.7
29
85
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
6.5
6.7
16
25
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.9
6.6
101
577
N06AA09
ATC
amitriptyline; systemic
2.6
6.6
46
184
ZXD35
NOMESCO Finland
Usual procedure
3.6
6.6
28
81
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.6
6.6
44
174
S20.2
ICD-10 Finland
Contusion of thorax
3.4
6.5
29
87
SPAT1050
SPAT
Extensive neurological examination
5.4
6.5
18
34
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
5.8
6.5
17
30
EBA00
NOMESCO Finland
Extraction of tooth
1.7
6.5
150
976
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
6.5
222
1603
N40
ICD-10 Finland
Hyperplasia of prostate
1.6
6.5
212
1515
LAITO
NOMESCO Finland
NA
70.5
6.4
7
*
JX1LA
NOMESCO Finland
Kinetic X-ray of alimentary tract with pictures
70.5
6.4
7
*
S63.1
ICD-10 Finland
Dislocation of finger
7.5
6.4
14
19
S09.9
ICD-10 Finland
Unspecified injury of head
14.5
6.4
10
7
SPAT1304
SPAT
Counselling and guidance related to ageing
2.2
6.4
64
309
M01AC06
ATC
meloxicam; systemic, rectal
1.6
6.4
180
1237
M54
ICD-10 Finland
Dorsalgia
2.3
6.3
54
242
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.0
6.3
78
408
B03BA03
ATC
hydroxocobalamin; parenteral
2.4
6.3
51
222
H50.52
ICD-10 Finland
Exophoria
18.2
6.3
9
5
F009, G309
ICD-10 Finland
NA
+∞
6.3
6
*
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
+∞
6.3
6
*
F02.89*G40.9
ICD-10 Finland
Dementia in epilepsy
+∞
6.3
6
*
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
+∞
6.3
6
*
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
+∞
6.3
6
*
G72.9
ICD-10 Finland
Myopathy, unspecified
+∞
6.3
6
*
I63.1
ICD-10 Finland
Cerebral infarction due to embolism of precerebral arteries
+∞
6.3
6
*
F0009, G300
ICD-10 Finland
NA
+∞
6.3
6
*
S00.0
ICD-10 Finland
Superficial injury of scalp
5.1
6.2
18
36
D12
ICPC
Constipation
3.3
6.2
29
91
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.3
6.2
53
239
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
2.9
6.1
35
125
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
5.0
6.1
18
37
N30
ICD-10 Finland
Cystitis
2.7
6.1
39
149
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
6.1
170
1164
N06AG02
ATC
moclobemide; oral
4.6
6.0
19
42
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3019309) Folate [Moles/volume] in Red Blood Cells
292
1135
3.52
59.14
2.1
1.7
nmol/l
1120.6
1141.2
0.13
192
809
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
289
1298
2.95
43.52
2.8
1.8
u/l
341.9
273.8
0.34
266
1179
(3014271) Vancomycin [Susceptibility]
32
24
13.86
34.13
5.0
3.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
333
1811
2.47
32.13
4.8
3.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
315
1715
2.41
29.82
4.1
4.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
23
21
11.26
21.63
1.2
1.1
e6/l
1.7
280.6
0.55
16
16
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
23
21
11.26
21.63
1.5
1.1
e6/l
58.8
212.0
0.37
18
16
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
94
325
3.15
21.33
1.4
1.4
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
500
3614
2.07
20.45
7.4
4.4
e6/l
6209.6
3086.2
0.24
14
45
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
196
1008
2.26
19.87
2.0
1.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
23
25
9.45
19.17
1.3
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
329
2133
1.94
17.46
5.5
3.6
ng/l
45.7
83.3
1.20
271
1666
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
18
17
10.82
16.48
2.8
2.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
212
1213
2.03
15.88
1.9
1.7
pmol/l
391.7
21826237.7
1.04
164
953
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
363
2485
1.86
15.86
2.4
2.0
pmol/l
82.1
91.4
4.18
222
1221
(3021960) Folate [Moles/volume] in Serum or Plasma
232
1426
1.89
13.81
1.7
1.5
nmol/l
17.5
19.6
1.52
203
1153
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
44
127
3.61
13.23
1.5
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
44
127
3.61
13.23
1.5
1.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
315
2160
1.77
12.94
3.9
3.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
134
697
2.11
12.73
2.0
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
135
708
2.10
12.55
2.0
1.6
—
—
—
0
0
(3026782) Osmolality of Urine
202
1233
1.86
12.06
4.1
2.9
mosm/kgh2o
610.3
558.8
2.99
171
1032
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
386
2866
1.69
11.47
5.0
6.5
mmol/l
1.2
1.2
1.24
295
2414
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
393
4920
0.59
11.40
3.6
4.4
mmol/l
1.4
1.4
0.88
321
4288
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
13
13
10.15
11.36
1.0
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
282
1929
1.72
11.33
2.6
1.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
401
4983
0.60
11.12
3.5
4.5
mmol/l
4.2
4.4
3.14
329
4397
(3002582) Erythrocytes [#/volume] in Urine
273
1880
1.70
10.54
4.0
3.4
e6/l
54.5
156.4
0.87
217
1452
(3030467) Casts [#/volume] in Urine by Automated count
257
1742
1.71
10.52
3.7
3.3
e6/l
0.5
0.5
0.29
201
1317
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
61
1317
0.42
10.17
1.2
1.5
mmol/l
1.0
1.2
2.57
52
1064
(3037467) Urinalysis macro (dipstick) panel - Urine
469
3732
1.65
10.13
6.3
4.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
347
2565
1.64
10.07
4.7
5.6
mmol/l
1.2
1.2
0.21
297
2279
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
236
1579
1.71
10.05
2.2
2.2
mg/l
2.8
3.1
1.48
169
1311
(3013826) Glucose [Moles/volume] in Serum or Plasma
417
3229
1.63
10.00
5.0
4.3
mmol/l
6.5
6.9
6.51
391
3017
(3024891) Influenza virus A+B Ag [Presence] in Specimen
33
95
3.58
9.99
1.4
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
107
1864
0.51
9.81
2.8
3.0
mmol/l
7.0
7.1
0.05
74
1484
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
429
5173
0.62
9.55
4.0
5.2
mmol/l
2.4
2.5
2.97
346
4524
(3012516) Albumin [Mass/volume] in Urine
109
1869
0.52
9.45
2.7
3.2
mg/l
732.8
189.4
0.36
63
1187
(3020682) Albumin/Creatinine [Ratio] in Urine
122
2008
0.53
9.21
3.8
3.9
mg/mmol
6.0
7.9
0.65
71
1269
(36304419) Bacteria [Presence] in Urine
238
1629
1.66
9.17
3.8
3.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
270
1913
1.63
9.05
6.4
3.9
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
332
2475
1.60
9.01
3.3
4.6
g/l
33.3
34.0
1.31
282
2260
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
385
4727
0.63
8.90
3.2
4.0
mmol/l
1.1
1.2
2.55
305
4070
(3018095) Leukocytes [#/volume] in Urine
290
2105
1.60
8.74
4.6
3.8
e6/l
119.3
159.2
0.39
222
1528
(3000850) Epithelial cells [#/volume] in Urine
192
1259
1.70
8.63
3.3
2.7
e6/l
4.2
4.2
0.00
164
1088
(3016018) Differential panel - Cerebral spinal fluid
11
13
8.57
8.48
1.3
1.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
52
215
2.52
8.41
2.1
1.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
333
2519
1.56
8.29
5.6
3.5
estimate
0.0
0.0
0.00
73
479
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
42
157
2.77
8.28
2.3
2.6
ug/l
491.9
294.5
0.49
36
151
(3023410) Appearance of Cerebral spinal fluid
12
7
17.39
8.09
1.3
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
25
70
3.66
7.90
1.7
2.3
umol/l
25.9
33.8
1.31
16
59
(3009261) Glucose [Presence] in Urine by Test strip
335
2562
1.54
7.80
5.8
3.6
estimate
0.0
0.0
0.00
78
474
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
109
624
1.87
7.73
6.0
3.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
329
2514
1.53
7.65
7.9
5.0
estimate
0.0
0.0
0.00
74
473
(3029937) Albumin [Presence] in Urine by Test strip
197
1343
1.63
7.50
5.8
3.7
estimate
0.0
0.0
0.50
66
446
(3006653) Thiamine [Moles/volume] in Blood
10
5
20.23
7.14
1.1
1.0
nmol/l
141.4
132.4
—
10
5
(3036481) Cortisol [Moles/volume] in Serum or Plasma
67
333
2.11
7.10
1.7
2.2
nmol/l
408.4
403.3
0.07
48
302
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
10
6
16.86
6.75
1.1
1.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
52
241
2.24
6.56
2.2
2.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
38
157
2.49
6.20
1.3
1.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
247
1848
1.49
6.02
2.2
3.6
mmol/l
2.3
2.3
1.43
192
1534
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
152
1031
1.59
5.77
3.3
3.1
e6/l
2.7
1.7
0.83
87
608
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
256
1949
1.47
5.65
2.1
2.0
nmol/l
71.4
80.9
6.10
192
1627
(3018418) pH of Serum or Plasma
228
1698
1.48
5.62
2.5
3.9
ph
7.4
7.4
1.69
49
302
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
40
178
2.31
5.58
5.2
4.0
mmol/l
25.9
24.5
1.87
34
158
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
71
394
1.88
5.55
2.3
1.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
40
806
0.47
5.35
3.9
4.7
ug/l
3.2
38.0
2.34
33
689
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
156
1083
1.55
5.33
3.0
2.9
e6/l
1.1
1.0
0.14
91
657
(3006270) Folate [Moles/volume] in Blood
15
39
3.90
5.28
1.3
1.2
nmol/l
330.8
304.2
—
8
25
(3012501) Base excess in Blood by calculation
30
120
2.56
5.26
3.4
4.4
mmol/l
1.9
2.7
1.06
23
74
(3041096) Erythrocytes [Presence] in Urine by Automated
184
1330
1.50
5.21
6.2
3.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
153
1067
1.54
5.11
5.4
3.6
kg/l
1.0
1.0
1.22
19
174
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
89
543
1.72
5.09
2.4
2.3
ug/l
5.7
6.4
0.20
39
482
(40768800) Prostate Pathology biopsy report
5
238
0.20
4.92
1.0
1.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
54
292
1.91
4.59
4.2
3.8
mmol/l
2.4
1.8
0.60
38
205
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
5
14.11
4.58
1.0
1.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
437
4965
0.73
4.53
22.7
15.9
ml/min/173m2
77.8
68.5
17.82
362
4006
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
65
375
1.80
4.52
1.8
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
67
392
1.78
4.45
4.4
4.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
92
593
1.63
4.29
2.7
3.3
mmol/l
2.8
1.8
2.03
76
444
(3007853) Bacteria identified in Skin by Aerobe culture
90
578
1.63
4.26
1.6
1.7
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
154
1117
1.47
4.22
2.7
3.4
mmol/l
2.5
2.5
0.55
121
951
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
409
3506
1.35
4.14
3.6
3.4
pmol/l
15.4
15.2
0.48
335
3020
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
435
4916
0.74
4.12
6.2
6.5
mmol/mol
40.9
40.9
0.04
360
4355
(1761868) Lipid panel - Serum or Plasma
87
1302
0.63
4.11
3.9
3.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
110
755
1.53
3.93
10.2
6.8
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
122
858
1.50
3.89
1.7
2.8
mmol/l
0.8
0.8
0.16
103
787
(3009343) pH of Capillary blood
54
309
1.80
3.88
4.4
3.8
ph
7.4
7.4
—
9
36
(3032080) INR in Blood by Coagulation assay
309
2560
1.34
3.84
12.5
11.0
inr
1.4
1.4
0.62
85
681
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
460
5134
0.75
3.83
4.4
5.0
mmol/l
6.1
6.1
0.45
357
4438
(3001122) Ferritin [Mass/volume] in Serum or Plasma
250
2012
1.36
3.74
2.6
2.7
ug/l
164.1
179.4
0.41
193
1781
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
54
313
1.78
3.73
4.4
3.8
kpa
5.2
5.0
0.72
47
279
(40761536) Microorganisms panel - Urine sediment
73
461
1.64
3.71
6.8
3.8
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
8
12
6.72
3.68
1.0
2.1
ug/l
70.0
52.3
—
8
12
(40768804) Tissue Pathology biopsy report
169
2176
0.71
3.64
2.2
2.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
13
353
0.36
3.62
1.3
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
563
5138
1.35
3.38
25.1
15.4
mg/l
32.9
30.7
0.70
515
4086
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
13
43
3.06
3.26
1.5
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
13
43
3.06
3.26
1.5
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
23
103
2.27
3.25
2.4
2.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
26
125
2.12
3.11
2.4
4.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
16
62
2.61
3.06
1.5
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
16
62
2.61
3.06
1.5
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
16
62
2.61
3.06
1.5
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
16
62
2.61
3.06
1.5
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
130
1699
0.72
2.99
2.7
3.5
ug/l
0.7
0.9
1.41
87
1259
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
16
63
2.57
2.97
1.5
1.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
75
505
1.54
2.95
2.9
3.6
mmol/l
1.2
1.2
0.69
62
435
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
47
282
1.71
2.93
1.9
1.8
ug/l
1.8
2.0
0.06
30
245
(3027945) Reticulocytes/100 erythrocytes in Blood
112
821
1.43
2.89
1.6
2.3
%
1.6
1.7
0.54
84
719
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
9
6.71
2.87
1.0
1.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
25
469
0.52
2.76
3.2
3.0
ml/min/173m2
72.6
55.2
0.90
12
212
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
99
718
1.43
2.71
4.4
6.7
kpa
5.1
5.1
0.15
92
678
(3027801) Oxygen [Partial pressure] in Arterial blood
99
718
1.43
2.71
4.5
6.7
kpa
11.4
12.2
0.65
91
679
(3044640) Blood type and Crossmatch panel - Blood
217
1785
1.30
2.66
2.1
2.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
18
370
0.47
2.61
1.1
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
98
718
1.42
2.55
4.5
6.7
mmol/l
1.8
1.0
1.66
79
558
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
73
506
1.49
2.53
1.6
2.1
g/l
0.2
0.2
0.01
65
469
(40761535) Cells panel - Urine sediment
70
481
1.50
2.53
3.6
2.7
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
195
1593
1.30
2.51
2.3
2.3
u/l
53.4
58.9
0.67
177
1429
(3026493) Urate [Moles/volume] in Serum or Plasma
112
1459
0.73
2.49
2.1
2.9
umol/l
10386.1
10743.6
0.02
80
1211
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
15
63
2.41
2.47
1.5
1.3
—
—
—
0
0
(4010399)
17
347
0.48
2.44
1.2
1.4
—
—
—
0
0
(3019225) pH of Specimen
81
578
1.45
2.43
4.8
4.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
0
63
0.00
2.43
0.0
1.5
—
—
—
0
0
(4035726)
34
561
0.59
2.42
1.1
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
37
597
0.60
2.42
1.2
1.2
iu/ml
84.0
53.2
0.21
12
182
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
331
2895
1.25
2.41
3.6
6.4
umol/l
12.3
13.7
1.20
296
2748
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
8
6.28
2.37
1.0
1.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
154
1227
1.32
2.37
4.7
3.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
16
329
0.48
2.35
1.1
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
60
406
1.52
2.35
1.6
2.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
17
341
0.49
2.33
1.2
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
35
566
0.60
2.31
1.3
1.2
u/ml
1.5
25.7
6.02
12
171
(3022313) Gas panel - Capillary blood
37
224
1.68
2.28
5.1
3.7
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
18
3.91
2.25
2.1
3.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
9
5.58
2.21
1.2
1.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
35
558
0.61
2.19
1.4
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
9
31
2.92
2.07
1.4
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
9
31
2.92
2.07
1.4
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
56
0.00
2.07
0.0
1.5
—
—
—
0
0
(3000492) Spirometry study
16
311
0.50
2.02
1.4
1.6
—
—
—
0
0
(4024509)
11
44
2.52
2.02
1.5
1.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
37
234
1.61
1.96
8.6
4.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
16
3.77
1.93
1.2
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
126
1005
1.30
1.93
1.7
1.5
mg/l
1.8
1.9
0.09
98
793
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
292
2568
1.22
1.92
3.2
2.8
u/l
57.1
60.4
0.11
257
2267
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
488
4515
1.22
1.90
4.7
4.1
mu/l
2.0
2.2
2.06
405
3865
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
14
65
2.17
1.89
3.3
2.3
—
—
—
0
0
(3004451) EKG impression Narrative
8
28
2.88
1.86
1.5
1.2
—
—
—
0
0
(3020891) Body temperature
33
207
1.62
1.82
3.8
3.9
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
43
288
1.52
1.81
1.6
3.6
mmol/l
25.7
23.8
2.65
38
262
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
460
4248
1.20
1.76
4.9
7.4
u/l
83.6
85.0
0.17
402
3922
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
33
210
1.60
1.73
1.7
1.4
%
1.5
1.6
0.38
26
170
(3026389) Candida sp identified in Specimen by Organism specific culture
11
48
2.31
1.71
1.3
1.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
0
47
0.00
1.71
0.0
1.2
—
9.2
—
0
35
(4281824)
0
49
0.00
1.69
0.0
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
32
205
1.59
1.65
1.7
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
61
815
0.73
1.61
1.5
1.4
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
44
0.00
1.51
0.0
2.4
—
150.5
—
0
6
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
144
1205
1.24
1.50
4.1
3.7
ng/l
72.0
696.9
2.59
129
1077
(3037522) Nuclear Ab [Titer] in Serum
30
450
0.65
1.50
1.2
1.3
titre
230.0
537.9
—
8
103
(3044927) Protein electrophoresis panel - Urine
12
58
2.09
1.49
1.7
1.2
—
—
—
0
0
(1002224) Polysomnography panel
7
28
2.51
1.45
1.0
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
23
362
0.62
1.43
1.6
2.0
nmol/l
13.6
10.9
0.81
17
305
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
136
0.44
1.41
1.2
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
46
331
1.41
1.40
3.5
2.9
e6/l
0.5
0.3
0.24
46
324
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
526
5537
0.85
1.39
8.6
10.6
u/l
16.7
23.3
9.17
455
5208
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
162
0.49
1.37
1.0
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
92
740
1.28
1.36
1.2
1.2
u/ml
0.6
1.4
1.56
20
172
(40767503) Oxygen content in Capillary blood by calculation
20
120
1.68
1.35
2.3
2.8
%
16.8
15.3
—
9
60
(3022806) Fractional oxyhemoglobin in Capillary blood
14
75
1.88
1.35
2.2
2.0
%
88.9
88.3
0.15
14
75
(3023520) Reticulocytes [#/volume] in Blood
79
624
1.30
1.34
1.7
2.4
e9/l
59.3
65.5
1.24
61
485
(4034850)
23
144
1.62
1.33
13.4
10.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
12
220
0.54
1.33
1.1
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
40
0.00
1.33
0.0
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
29
193
1.52
1.31
2.7
3.2
pmol/l
4.3
4.3
0.10
21
164
(4094501)
5
115
0.43
1.26
1.0
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
474
4458
1.16
1.25
25.8
18.2
%
36.0
37.4
1.39
229
2639
(3020630) Protein [Mass/volume] in Serum or Plasma
66
515
1.31
1.24
1.5
2.5
g/l
64.8
66.0
0.45
47
461
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
209
2349
0.85
1.23
3.8
5.0
%
20.0
22.3
1.61
108
1358
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
19
116
1.65
1.22
1.5
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
7
141
0.49
1.21
3.0
2.2
—
—
—
0
0
(3044889) 12 lead EKG panel
366
3939
0.87
1.21
4.4
4.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
34
0.00
1.16
0.0
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
34
0.00
1.16
0.0
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
19
295
0.64
1.15
1.1
1.2
—
—
—
0
0
(44813793)
5
20
2.51
1.15
1.0
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
21
136
1.56
1.09
1.5
1.5
ug/g
264.2
256.5
0.06
13
87
(40768797) Stomach Pathology biopsy report
53
678
0.77
1.09
1.2
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
92
764
1.23
1.06
1.6
1.9
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
9
46
1.97
1.04
2.7
1.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
199
1783
1.16
0.99
4.8
5.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
20
295
0.67
0.98
1.3
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
10
54
1.86
0.97
1.5
1.7
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
16
101
1.60
0.94
1.3
1.7
e6/l
18458.6
15179.8
—
10
68
(3003694) ABO and Rh group [Type] in Blood
121
1390
0.85
0.93
1.2
1.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
115
991
1.19
0.93
1.8
2.4
umol/l
11.1
12.2
1.02
93
918
(3019832) Treponema pallidum Ab [Presence] in Serum
12
71
1.70
0.89
1.2
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
41
525
0.77
0.88
1.2
1.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
157
1401
1.15
0.83
3.3
3.6
%
78.9
80.7
0.41
150
1365
(3004789) Transferrin [Mass/volume] in Serum or Plasma
107
930
1.17
0.80
1.8
2.4
g/l
2.1
2.2
2.21
80
858
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
27
0.00
0.77
0.0
1.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
261
2420
1.12
0.76
5.5
5.8
%
21.2
25.4
8.28
223
2214
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
57
469
1.23
0.76
2.1
2.3
u/l
44.7
37.7
0.21
42
401
(3024263) Appearance of Synovial fluid
5
24
2.09
0.74
1.2
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
404
3840
1.11
0.74
3.5
3.8
mm/h
13.3
15.5
2.19
345
3430
(3001019) Free T4 and TSH panel - Serum or Plasma
7
38
1.85
0.73
2.3
1.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
276
2572
1.11
0.73
4.9
5.2
e9/l
0.2
0.2
6.60
225
2160
(3044941) Cell count panel - Synovial fluid
11
68
1.63
0.72
1.4
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
38
475
0.79
0.70
2.0
4.2
%
0.8
0.8
—
8
162
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
9
142
0.63
0.70
1.2
1.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
249
2313
1.11
0.70
5.0
5.6
%
0.5
0.6
2.83
214
2131
(3052851) Hemolysis interference index of Serum or Plasma
24
178
1.36
0.69
1.8
3.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
101
887
1.16
0.68
2.0
2.4
%
21.3
22.1
0.23
71
753
(3017732) Neutrophils [#/volume] in Blood
35
277
1.28
0.66
3.3
2.8
e9/l
4.0
4.5
0.54
15
182
(3021589) Normoblasts [#/volume] in Blood
221
2378
0.90
0.64
12.3
9.7
e9/l
0.0
0.0
2.40
174
1899
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
231
2147
1.11
0.64
3.3
2.9
ng/l
1771.2
2056.9
0.43
190
1868
(3003458) Phosphate [Moles/volume] in Serum or Plasma
83
722
1.17
0.64
2.2
4.8
mmol/l
0.9
1.1
4.79
73
665
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
25
190
1.33
0.63
1.4
1.9
g/l
35.3
36.7
0.36
13
160
(3018010) Neutrophils/100 leukocytes in Blood
254
2375
1.10
0.62
5.4
5.5
%
63.8
59.1
7.52
219
2188
(3019198) Lymphocytes [#/volume] in Blood
270
2536
1.10
0.60
4.8
5.2
e9/l
1.5
1.8
5.01
226
2149
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
9
141
0.63
0.60
2.7
2.0
g/l
3.6
3.5
—
9
132
(3044007) Cell count panel - Peritoneal fluid
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
2.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
48
400
1.21
0.60
5.4
3.2
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
22
0.00
0.59
0.0
1.5
—
76322.0
—
0
14
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
0
22
0.00
0.59
0.0
2.0
—
493.3
—
0
10
(3019069) Monocytes/100 leukocytes in Blood
254
2383
1.10
0.58
5.1
5.8
%
8.6
9.2
2.01
218
2199
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
23
0.00
0.58
0.0
1.4
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
0
23
0.00
0.58
0.0
2.5
—
38.4
—
0
5
(3006504) Eosinophils/100 leukocytes in Blood
253
2374
1.10
0.58
4.7
5.6
%
2.3
2.9
4.61
217
2185
(3002179) Metamyelocytes/100 leukocytes in Blood
34
418
0.80
0.57
2.1
4.4
%
2.7
0.6
—
7
114
(3021440) Promyelocytes/100 leukocytes in Blood
37
450
0.81
0.57
2.1
4.2
%
0.1
0.1
—
7
150
(3024928) Oxygen saturation in Venous blood
19
141
1.36
0.56
1.1
3.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
6
36
1.67
0.56
1.0
1.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
86
0.58
0.56
1.0
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
271
2563
1.09
0.52
3.6
4.5
—
—
—
0
0
(3013512) EKG study
196
1827
1.10
0.52
5.1
4.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
10
145
0.69
0.51
1.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
6
41
1.47
0.50
1.0
1.9
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
22
171
1.29
0.50
1.4
2.0
g/l
0.0
0.2
0.97
14
155
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
27
216
1.26
0.50
1.3
2.3
g/l
3.3
3.3
0.01
13
171
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
62
707
0.87
0.48
3.5
4.3
%
38.3
33.4
1.28
27
391
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
67
590
1.15
0.47
1.6
2.4
umol/l
11.6
13.3
0.17
53
513
(3009445) Proteinase 3 Ab [Units/volume] in Serum
17
221
0.76
0.46
1.2
1.7
—
22.9
—
0
10
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
16
120
1.34
0.46
1.1
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
237
1.23
0.46
1.3
2.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
237
1.23
0.46
1.3
2.2
g/l
4.2
3.7
0.27
14
167
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
237
1.23
0.46
1.3
2.2
g/l
6.8
7.6
0.84
14
174
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
11
153
0.71
0.46
1.2
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
274
2877
0.93
0.45
4.1
6.0
ug/l
2.7
5.0
2.97
213
2530
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
18
231
0.77
0.45
2.2
2.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
7
50
1.40
0.45
1.1
1.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
261
2479
1.08
0.45
4.4
5.1
e9/l
0.6
0.6
1.53
213
2049
(3014765) Yersinia sp identified in Stool by Organism specific culture
16
121
1.33
0.44
1.1
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
74
660
1.13
0.44
2.3
2.9
ng/l
238.5
279.8
0.30
66
604
(40761511) CBC panel - Blood by Automated count
542
5293
1.08
0.43
24.6
15.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
16
122
1.32
0.42
1.3
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
16
122
1.32
0.42
1.1
1.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
262
2494
1.08
0.42
4.4
5.1
e9/l
0.0
0.0
3.40
214
2063
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
92
0.65
0.42
1.5
1.6
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
32
1.57
0.42
1.6
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
15
0.00
0.41
0.0
1.8
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
2.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
20
249
0.80
0.40
1.5
1.2
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
0
17
0.00
0.40
0.0
3.2
—
0.1
—
0
17
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
25
205
1.23
0.39
1.6
2.2
g/l
1.6
1.5
0.02
16
169
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
71
1.41
0.39
2.3
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
42
363
1.17
0.39
2.6
2.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
106
0.66
0.39
1.1
1.3
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
19
0.00
0.39
0.0
2.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
147
1373
1.09
0.38
2.1
2.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
17
214
0.79
0.38
2.1
1.9
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
111
0.72
0.37
1.4
1.5
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
8
113
0.70
0.37
3.0
1.8
%
92.2
82.2
—
8
107
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
47
412
1.15
0.37
2.4
3.4
ng/l
69.6
97.4
1.69
34
349
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
23
189
1.22
0.36
2.4
2.4
—
14.0
—
0
5
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
43
1.40
0.35
1.3
1.2
nmol/l
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
406
4174
0.94
0.34
27.1
20.0
%
13.8
14.0
3.61
387
4053
(3004716) Salmonella sp identified in Stool by Organism specific culture
17
136
1.26
0.34
1.1
1.2
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
6
46
1.31
0.33
1.0
1.6
—
72.3
—
0
33
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
27
230
1.18
0.31
1.3
2.2
g/l
8.3
10.8
3.26
15
190
(3051387) C reactive protein [Mass/volume] in Capillary blood
19
156
1.22
0.31
8.2
3.2
mg/l
23.8
29.4
0.35
13
102
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
98
0.71
0.31
1.1
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
153
1448
1.07
0.30
1.9
2.8
u/l
43.9
34.1
0.41
135
1357
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
27
231
1.17
0.30
1.3
3.6
mg/l
26.1
78.8
1.45
19
198
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
14
174
0.80
0.30
1.1
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
19
228
0.83
0.30
1.3
1.3
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
27
232
1.17
0.29
1.3
3.6
mg/l
50.8
325.9
0.61
20
195
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
35
397
0.88
0.29
1.5
1.5
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
8
110
0.72
0.29
2.0
2.5
%
56.0
60.8
—
8
110
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
63
1.27
0.28
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
17
140
1.22
0.27
1.5
1.6
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
26
224
1.17
0.27
1.2
3.5
—
1.5
—
0
14
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
20
168
1.20
0.27
1.4
2.0
g/l
0.0
0.0
0.00
12
153
(4146454)
8
65
1.23
0.27
2.5
2.8
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
10
126
0.79
0.24
1.4
1.5
mg/l
8.3
12.5
—
10
110
(40760888) Immunoglobulin light chains.free panel - Serum
21
180
1.17
0.24
1.1
3.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
28
247
1.14
0.23
1.7
2.3
u/ml
0.5
0.3
0.78
13
140
(3000012) Reticulocyte production index
5
39
1.28
0.23
1.0
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
11
88
1.25
0.22
1.6
3.2
e9/l
5.0
3.9
0.47
11
88
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
14
167
0.84
0.22
1.4
2.5
ug/min
48.9
78.2
—
5
95
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
10
0.00
0.21
0.0
3.6
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
0
10
0.00
0.21
0.0
3.6
—
5.1
—
0
10
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
37
408
0.90
0.21
2.1
4.2
%
0.0
0.2
—
7
119
(3012441) Differential panel - Pleural fluid
8
102
0.78
0.21
1.1
1.5
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
8.8
—
0
12
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
12
0.00
0.21
0.0
1.8
—
1.9
—
0
12
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
78
830
0.93
0.21
1.7
4.0
u/l
228.3
250.2
1.09
65
780
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
16
187
0.85
0.20
1.1
1.1
iu/ml
97.4
154.7
—
5
55
(3003338) MCHC [Mass/volume]
415
4074
1.04
0.20
28.0
21.9
g/l
330.2
331.0
0.97
394
4024
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
48
1.25
0.20
1.0
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
6
48
1.25
0.20
1.2
1.6
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.6
—
1.0
—
0
14
(37021550) Renin [Units/volume] in Plasma --upright
0
14
0.00
0.20
0.0
1.4
—
48.9
—
0
9
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
1.3
—
0
5
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
52
1.16
0.19
1.3
1.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
307
3003
1.04
0.18
6.2
8.7
e9/l
4.8
4.3
1.61
255
2538
(3000330) Specific gravity of Urine by Test strip
43
397
1.09
0.17
8.1
3.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
62
1.13
0.17
1.4
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
66
0.76
0.17
1.0
1.2
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
19
167
1.14
0.17
1.4
2.0
g/l
0.0
0.0
0.00
12
153
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
69
0.72
0.17
1.0
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
33
360
0.91
0.16
7.7
9.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
11
92
1.20
0.16
1.7
3.8
%
56.2
56.6
0.04
11
92
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
9
80
1.13
0.15
1.9
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
9
80
1.13
0.15
1.1
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
30
327
0.91
0.15
2.2
3.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
566
5607
1.03
0.14
28.4
19.0
mmol/l
139.8
139.5
2.03
541
5425
(3039443) Prostate specific Ag panel - Serum or Plasma
7
87
0.80
0.14
1.9
1.9
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
87
0.80
0.14
1.1
1.3
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
566
5610
1.03
0.13
28.4
19.2
mmol/l
4.0
4.0
5.41
540
5423
(3028626) Oxygen [Partial pressure] in Capillary blood
11
125
0.88
0.10
2.2
3.6
kpa
8.1
7.6
0.52
11
114
(40760892) CBC W Ordered Manual Differential panel - Blood
99
960
1.04
0.10
3.7
4.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
44
1.14
0.10
1.2
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
45
1.11
0.10
1.2
1.9
%
8.1
9.9
—
5
45
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
46
1.09
0.09
1.4
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
130
1269
1.03
0.09
5.8
6.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
56
1.07
0.08
1.5
1.4
—
—
—
0
0
(3035880) pH of Pleural fluid
6
56
1.07
0.08
1.0
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
5
63
0.79
0.08
1.4
1.0
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
53
551
0.96
0.08
2.3
5.4
mmol/l
10.4
12.5
1.32
44
517
(3023419) Bacteria identified in Sputum by Culture
7
66
1.06
0.08
3.0
2.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
81
0.86
0.07
1.4
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
84
0.83
0.07
1.3
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
85
0.82
0.07
1.1
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
86
1.05
0.07
1.0
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
8
93
0.86
0.06
1.3
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
9
100
0.90
0.06
1.3
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
9
102
0.88
0.06
2.7
2.9
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
15
162
0.92
0.06
1.1
1.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
39
379
1.03
0.03
2.1
1.8
ug/g
251.9
151.9
0.77
27
288
(3003327) Ova and parasites identified in Stool by Light microscopy
11
103
1.07
0.02
1.5
1.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
52
527
0.99
0.01
3.1
7.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
12
114
1.05
0.00
1.2
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
17
165
1.03
0.00
1.8
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
11
106
1.04
0.00
1.6
3.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
36
357
1.01
0.00
1.4
1.7
g/l
1.5
1.5
0.22
25
304
(3007164) IgA [Mass/volume] in Serum or Plasma
70
698
1.00
0.00
1.2
1.5
g/l
2.2
2.9
2.08
31
390
(3035941) MCH [Entitic mass]
568
5681
1.00
0.00
33.0
23.4
pg
30.6
30.5
0.44
540
5529
(3024731) MCV [Entitic volume]
568
5681
1.00
0.00
33.0
23.4
fl
92.3
91.9
1.28
540
5528
(3026361) Erythrocytes [#/volume] in Blood
568
5681
1.00
0.00
33.1
23.5
e12/l
4.2
4.4
16.56
535
5409
(3000963) Hemoglobin [Mass/volume] in Blood
568
5681
1.00
0.00
33.4
23.6
g/l
126.1
132.1
19.63
540
5533
(3010813) Leukocytes [#/volume] in Blood
568
5681
1.00
0.00
33.2
23.5
e9/l
7.0
7.0
0.13
534
5407
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
7.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
6
0.00
0.00
0.0
6.0
—
14.1
—
0
6
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
5
52
0.96
0.00
1.0
1.2
—
114.4
—
0
5
(3024471) HLA-A [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
2006.8
—
0
6
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
60
1.00
0.00
1.0
1.1
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
73
0.96
0.00
1.9
4.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
73.4
—
0
5
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
51
0.98
0.00
1.0
1.9
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
67
0.89
0.00
1.3
3.5
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
86
0.93
0.00
1.3
3.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
10.9
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
69
0.87
0.00
1.3
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
49
1.02
0.00
1.4
1.2
—
—
—
0
0
(4212803)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
1.0
—
24.8
—
0
5
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
61
0.98
0.00
1.2
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
49
1.02
0.00
1.0
1.9
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
14
140
1.00
0.00
2.0
3.7
mmol/l
24.8
24.7
0.05
14
121
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
8
0.00
0.00
0.0
4.8
—
5.9
—
0
8
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
7
0.00
0.00
0.0
4.7
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
568
5680
1.00
0.00
33.1
23.5
e9/l
232.2
232.6
0.06
534
5436
(3023511) Choriogonadotropin [Units/volume] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
7
74
0.95
0.00
1.9
5.4
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint PD_DEMENTIA_EXMORE and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| PD_DEMENTIA_EXMORE | 4.002 [3.47, 4.62] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.35 |
During the follow-up period (1.1.1998 — 31.12.2019), 2678 out of 3661 females with PD_DEMENTIA_EXMORE died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| PD_DEMENTIA_EXMORE | 4.506 [3.75, 5.41] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.032 |
During the follow-up period (1.1.1998 — 31.12.2019), 3543 out of 4687 males with PD_DEMENTIA_EXMORE died.
Mortality risk
Mortality risk for people of age
years, who have PD_DEMENTIA_EXMORE.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.287% | 1.034% |
| 5 | 2.261% | 5.714% |
| 10 | 5.45% | 13.843% |
| 15 | 10.744% | 24.757% |
| 20 | 18.651% | 38.964% |
Relationships between endpoints
↥Index endpoint: PD_DEMENTIA_EXMORE – Dementia due to Parkinsons disease, excluding more controls
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data